AstraZeneca Scores a Legal Win in the Ongoing 340B Discount Drug Program Saga

A federal judge has ruled that the government incorrectly threatened AstraZeneca with fines for limiting discounts to the controversial 340B Drug Discount program for safety-net hospitals.
Source: Drug Industry Daily